NSRX Nasus Pharma Ltd.
Company Analysis
Latest News
🔴 Nasus Pharma is trading 5.3% down in after-hours trading with no clear company-specific catalyst
Nasus Pharma is trading 5.3% down at $3.10 after the October 13 regular-session close at $3.27; no clear company-specific catalyst has been identified for the...
🔴 Nasus Pharma is trading 5% down today amid healthcare-sector weakness
Nasus Pharma is trading 5.12% down at $3.15, with no clear company-specific catalyst identified for October 13, 2026. - The healthcare sector is down 1.37%,...
🔴 Nasus Pharma is trading 6% down on October 12, 2026
Nasus Pharma is trading 5.98% down at $3.30, with no clear company-specific catalyst identified for October 12, 2026. - The latest located company...
🟢 Nasus Pharma is trading 5.8% up in after-hours trading with no identified company-specific catalyst
Nasus Pharma is trading 5.8% higher in after-hours trading at $3.65, versus its October 9 regular-session close of $3.51; no clear company-specific...
🔴 Nasus Pharma is trading 7.3% down on October 8, 2026 as inflation fears pressure stocks
Nasus Pharma is trading at $3.50, down 7.28%, during the October 8 session amid broad risk-off pressure, as higher oil prices and Treasury yields stoked...
🟢 Nasus Pharma is trading 7% up today alongside broader market gains
Nasus Pharma is trading at $4.09, up +7.21%, alongside a broader risk-on session; no company-specific cause has been established. - Major U.S. indexes are...
🟢 Nasus Pharma is trading 8.6% up today after first patient dosed in NS003 Phase 1
Nasus Pharma is trading 8.6% higher at $4.01 after the first patient was enrolled and dosed in its NS003 Phase 1 study. - The September 29 announcement...
🟢 Nasus Pharma is trading 12% up today after first NS003 patient enrolled and dosed
Nasus Pharma is trading 12.04% higher at $4.00 after announcing the first patient was enrolled and dosed in its Phase 1 NS003 study. - Announced September 29,...
🟢 Nasus Pharma is trading 11% up in pre-market after first NS003 patient enrolled and dosed
Nasus Pharma is trading at $3.95, up 10.64% in pre-market after the first patient was enrolled and dosed in its Phase 1 NS003 study. - Announced September 29,...
Nasus Pharma Starts First Human Trial for a Nasal Anti-Nausea Drug — But Can a $20 Million Company Deliver on the Promise?
Shares of Nasus Pharma surged as much as 12.6% to $4.02 after the micro-cap Israeli drugmaker announced it had dosed the first patient in a Phase 1 clinical...
🟢 Nasus Pharma is trading 11.51% up in after-hours trading after first NS003 Phase 1 patient dosed
Nasus Pharma is trading at $4.02, up 11.51% in after-hours trading following its September 29 announcement that the first patient was enrolled and dosed in...
🟢 Nasus Pharma is trading 5.7% up in after-hours trading after NS003 Phase 1 dosing
Nasus Pharma is trading 5.69% up at $3.81 after hours, following the announcement that the first patient was enrolled and dosed in its NS003 Phase 1 study. -...
🟢 Nasus Pharma is trading 5.6% up today after first patient dosing in Phase 1 NS003
Nasus Pharma is trading at $3.79 (+5.57%) after announcing the first patient was enrolled and dosed in its Phase 1 NS003 study. - Announced September 29, 2026,...
🟢 Nasus Pharma is trading 5% up
Nasus Pharma is trading 5.01% up at $3.65, with no new company-specific announcement explaining the September 28 move found in available search results. - The...
🔴 Nasus Pharma is trading 8% down today as 10-year Treasury yield hits 19-year high
Nasus Pharma is trading at $3.35, down 7.97%, amid broader risk-off pressure, though the sharper decline’s trigger remains unclear. - No reliable Nasus...
🟢 Nasus Pharma is trading 6.16% up today with no identified company-specific catalyst
Nasus Pharma is trading 6.16% higher at $3.79, with no reliable company-specific announcement identified to explain the gain. - No reliable announcement dated...
🟢 Nasus Pharma is trading 5% up today
Nasus Pharma is trading 5.23% up now at $3.62, with today’s gain more consistent with trading activity than a newly reported event. - No reliable...
🔴 Nasus Pharma is trading 5% down today
Nasus Pharma is trading at $3.35, down -5.10%, with no reliable catalyst currently explaining the decline. - No company-specific headlines were reported for...
🔴 Nasus Pharma is trading 5% down today
Nasus Pharma is trading 5.01% down now at $3.41, with no confirmed company-specific catalyst identified for the decline. - No new company-specific...
🔴 Nasus Pharma is trading 5.47% down today as Treasury yields reach a 19-year high
Nasus Pharma is trading at $3.45 (-5.47%) amid broad market pressure. • Broader markets are under pressure as Treasury yields reach a 19-year high and oil...